Plain-English translation of NCT06717581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing how bictegravir/tenofovir alafenamide/emtricitabine works in older adults with HIV who are already on stable treatment and have other health conditions requiring additional medications. The study wants to understand whether this medication combination safely works with the other drugs people are taking, without causing harmful interactions or reducing effectiveness.
Many people with HIV who are now older take multiple medications for other health problems like heart disease, diabetes, and kidney disease. This medication has been designed to have fewer drug interactions, but researchers need to study how it actually performs in real older patients who are juggling many medications at once.
You likely qualify if…
You likely don't qualify if…
You would take the medication combination as prescribed by your doctor while the study team monitors you to see how it interacts with your other medications. The study will track your health, medication levels, and any side effects over time to understand how well this treatment works alongside your other drugs. You'll likely have regular clinic visits and blood tests to ensure the medication is working safely.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy